This inventor holds 1 USPTO granted patent. Top assignee: Humboldt-Universitaet Zu Berlin. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: The Innovations of Hans-Joachim Binte
Introduction
Hans-Joachim Binte was a notable inventor whose contributions to the field of pharmaceuticals have left a lasting impact. He was based in Freiberg, Germany, and is remembered for his innovative work in developing compounds with significant pharmacological properties. His research focused on creating new 1-(2-hydroxyaryl)-alkane-1-on-oximes, which have various applications in medicine.
Latest Patents
Binte held a patent for a procedure involving 1-(2-hydroxyaryl)-alkane-1-on-oximes. This patent outlines the preparation and use of these compounds, which are characterized by their valuable pharmacological properties. The compounds are particularly noted for their potential in treating conditions such as asthma, allergic diseases, inflammatory and rheumatic diseases, and thrombosis. His work aimed to develop these compounds with desirable pharmacological properties, making them applicable in both human and veterinary medicine.
Career Highlights
Throughout his career, Hans-Joachim Binte made significant strides in pharmaceutical research. He was associated with the Humboldt University of Berlin, where he contributed to the academic and practical aspects of drug development. His innovative approach to creating new compounds has been influential in the field.
Collaborations
Binte collaborated with several notable individuals in his field, including Tankred Schewe and Joerg Beger. These collaborations helped to enhance the research and development of the compounds he worked on, furthering the impact of his inventions.
Conclusion
Hans-Joachim Binte's contributions to pharmaceutical innovations have had a profound effect on the treatment of various medical conditions. His legacy continues to inspire future research in the field of pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile